EGFR and Lymphadenopathy: In summary, logistic regression and decision tree models constructed using age, lymphadenopathy, pleural thickening, and brain metastasis show promise for noninvasive prediction of EGFR 19Del and 21L858R mutation subtypes in lung adenocarcinoma.